{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T06:35:18Z","timestamp":1792391718318,"version":"4.4.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1007\/s11920-996-0050-y","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T21:18:03Z","timestamp":1180732683000},"page":"299-306","source":"Crossref","is-referenced-by-count":26,"title":["Antipsychotic treatment for late-life schizophrenia"],"prefix":"10.1007","volume":"4","author":[{"given":"Jeremy A.","family":"Sable","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip V.","family":"Jeste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"50_CR1","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/archpsyc.56.9.848","volume":"56","author":"DV Jeste","year":"1999","unstructured":"Jeste DV, Alexopoulos GS, Bartels SJ, et al.: Consensus statement on the upcoming crisis in geriatric mental health: Research agenda for the next two decades. Arch Gen Psychiatry 1999, 56:848\u2013853. This paper describes the current shortage of available psychiatric treatment for older adults. The authors propose a 15- to 25-year agenda for the research of late-life psychiatric disorders (including schizophrenia) aimed at keeping pace with the projested growth of the population of older adults.","journal-title":"Arch Gen Psychiatry"},{"key":"50_CR2","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1176\/ps.50.9.1178","volume":"50","author":"BW Palmer","year":"1999","unstructured":"Palmer BW, Heaton SC, Jeste DV: Older patients with schizophrenia: challenges in the coming decades. Psychiatr Serv 1999, 50:1178\u20131183.","journal-title":"Psychiatr Serv"},{"key":"50_CR3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/10673220127883","volume":"9","author":"BW Palmer","year":"2001","unstructured":"Palmer BW, McClure F, Jeste DV: Schizophrenia in late-life: findings challenge traditional concepts. Harvard Rev Psychiatry 2001, 9:51\u201358.","journal-title":"Harvard Rev Psychiatry"},{"key":"50_CR4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/schbul\/19.4.817","volume":"19","author":"DV Jeste","year":"1993","unstructured":"Jeste DV, Lacro JP, Gilbert PL, et al.: Treatment of late-life schizophrenia with neuroleptics. Schizophr Bull 1993, 19:817\u2013830.","journal-title":"Schizophr Bull"},{"key":"50_CR5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1192\/bjp.101.423.281","volume":"101","author":"M Roth","year":"1955","unstructured":"Roth M: The natural history of mental disorder in old age. J Ment Sci 1955, 101:281\u2013301.","journal-title":"J Ment Sci"},{"key":"50_CR6","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1987","unstructured":"American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 3 [revised]. Washington, DC: American Psychiatric Press; 1987.","edition":"edn 3"},{"key":"50_CR7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/schbul\/14.1.39","volume":"14","author":"MJ Harris","year":"1988","unstructured":"Harris MJ, Jeste DV: Late-onset schizophrenia: an overview. Schizophr Bull 1988, 14:39\u201355.","journal-title":"Schizophr Bull"},{"key":"50_CR8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1176\/appi.ajp.157.2.172","volume":"157","author":"R Howard","year":"2000","unstructured":"Howard R, Rabins PV, Seeman MV, et al.: Late-onset schizophrenia and very-late-onset schizophrenia-like psychois: an international consensus. Am J Psychiatry 2000, 157:172\u2013178. This paper clarifies the diagnosis, nomenclature, and treatment guidelines for schizophrenia presenting in middle (age older than 40) and old (age older than 60) age. Findings are based on a systematic review of the literature and 2 days of discussion by members of the International Late-onset Schizophrenia Group.","journal-title":"Am J Psychiatry"},{"key":"50_CR9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/00019442-199700540-00005","volume":"5","author":"DV Jeste","year":"1997","unstructured":"Jeste DV, Symonds LL, Harris MJ, et al.: Non-dementia non-praecox dementia praecox? Late-onset schizophrenia. Am J Geriatr Psychiatry 1997, 5:302\u2013317.","journal-title":"Am J Geriatr Psychiatry"},{"key":"50_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0193-953X(18)30513-6","volume":"11","author":"DV Jeste","year":"1988","unstructured":"Jeste DV, Harris MJ, Pearlson GD, et al.: Late-onset schizophrenia: studying clinical validity. Psychiatr Clin North Am 1988, 11:1\u201314.","journal-title":"Psychiatr Clin North Am"},{"key":"50_CR11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archpsyc.1994.03950060033003","volume":"51","author":"R Heaton","year":"1994","unstructured":"Heaton R, Paulsen J, McAdams LA, et al.: Neuropsychological deficits in schizophrenia: Relationship to age, chronicity and dementia. Arch Gen Psychiatry 1994, 51:469\u2013476.","journal-title":"Arch Gen Psychiatry"},{"key":"50_CR12","first-page":"55","volume":"2","author":"DA Byrd","year":"1996","unstructured":"Byrd DA, Paulsen RK, Heaton RK, et al.: A qualitative analysis of intrusion erros in schizophrenia. J Int Neuropsychol Soc 1996, 2:55.","journal-title":"J Int Neuropsychol Soc"},{"key":"50_CR13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0165-1781(96)02901-0","volume":"63","author":"JS Paulsen","year":"1996","unstructured":"Paulsen JS, Romero R, Chan A, et al.: Impairment of the semantic network in schizophrenia. Psychiatry Res 1996, 63:109\u2013121.","journal-title":"Psychiatry Res"},{"key":"50_CR14","first-page":"3","volume-title":"The Transmission of Schizophrenia","author":"M Bleuler","year":"1968","unstructured":"Bleuler M: A 23-year longitudinal study of 208 schizophrenics and impressions in regard to the nature of schizophrenia. In The Transmission of Schizophrenia. Edited by Rosenthal D, Kety SS. New York: Pergamon Press; 1968:3\u201312."},{"key":"50_CR15","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/schbul\/6.4.592","volume":"6","author":"G Huber","year":"1980","unstructured":"Huber G, Gross G, Schuttler R, Linz M: Longitudinal studies of schizophrenia patients. Schizophr Bull 1980, 6:592\u2013605.","journal-title":"Schizophr Bull"},{"key":"50_CR16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1176\/ajp.144.6.727","volume":"144","author":"CM Harding","year":"1987","unstructured":"Harding CM, Brooks GW, Ashikaga T, et al.: The Vermont longitudinal study: II. Long-term outcome of subjects who once met the criteria for DSM-III schizophrenia. Am J Psychiatry 1987, 144:727\u2013735.","journal-title":"Am J Psychiatry"},{"key":"50_CR17","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/schbul\/14.4.645","volume":"14","author":"WT Carpenter","year":"1988","unstructured":"Carpenter WT, Kirkpatrick B: The heterogeneity of the long-term course of schizophrenia. Schizophr Bull 1988, 14:645\u2013652.","journal-title":"Schizophr Bull"},{"key":"50_CR18","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/schbul\/14.4.515","volume":"14","author":"TH McGlashan","year":"1988","unstructured":"McGlashan TH: A selective review of recent North American long-term followup studies of schizophrenia. Schizophr Bull 1988, 14:515\u2013542.","journal-title":"Schizophr Bull"},{"key":"50_CR19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/schbul\/19.4.683","volume":"19","author":"R Belitsky","year":"1993","unstructured":"Belitsky R, McGlashan TH: The manifestations of schizophrenia in late life: a dearth of data. Schizophr Bull 1993, 19:683\u2013685.","journal-title":"Schizophr Bull"},{"key":"50_CR20","first-page":"52","volume-title":"Schizophrenia and Aging","author":"G Winokur","year":"1987","unstructured":"Winokur G, Pfohl B, Tsuang M: A 40-year follow-up of hebephrenic-catatonic schizophrenia. In Schizophrenia and Aging. Edited by Miller NE, Cohen GD. New York: Guilford; 1987:52\u201360."},{"key":"50_CR21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/schbul\/6.4.606","volume":"6","author":"L Ciompi","year":"1980","unstructured":"Ciompi L: Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophr Bull 1980, 6:606\u2013618.","journal-title":"Schizophr Bull"},{"key":"50_CR22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1001\/archpsyc.58.1.24","volume":"58","author":"RK Heaton","year":"2001","unstructured":"Heaton RK, Gladsjo JA, Palmer BW, et al.: Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry 2001, 58:24\u201332. This paper compares the neuropsychologic performances of 142 patients with schizophrenia and 206 normal comparison subjects over a mean 3-year period. Although patients with schizophrenia show significantly more impairment than normal comparison subjects, the impairment appears to remain stable over time in community-dwelling outpatients.","journal-title":"Arch Gen Psychiatry"},{"key":"50_CR23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/089198879901200104","volume":"12","author":"JD Evans","year":"1999","unstructured":"Evans JD, Negron AE, Palmer BW, et al.: Cognitive deficits and psychopathology in hospitalized versus community-dwelling elderly schizophrenia patients. J Geriatr Psychiatry Neurol 1999, 12:11\u201315.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"50_CR24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00002512-199812020-00004","volume":"12","author":"RA Sweet","year":"1998","unstructured":"Sweet RA, Pollock BG: New atypical antipsychotics: experience and utility in the elderly. Drugs Aging 1998, 12:115\u2013127.","journal-title":"Drugs Aging"},{"key":"50_CR25","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2125.1980.tb01074.x","volume":"9","author":"FJ Rowell","year":"1980","unstructured":"Rowell FJ, Hui SM, Fairbairn AF, Eccleston D: The effect of age and thioridazine on the in vitro binding of fluphenazine to normal human serum. Br J Clin Pharmacol 1980, 9:432\u2013433.","journal-title":"Br J Clin Pharmacol"},{"key":"50_CR26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2165\/00002512-200017050-00004","volume":"17","author":"MP Caligiuri","year":"2000","unstructured":"Caligiuri MP, Jeste DV, Lacro JP: Antipsychotic-induced movement disorders in the elderly: epidemiology and treatment recommendations. Drugs Aging 2000, 17:363\u2013384.","journal-title":"Drugs Aging"},{"key":"50_CR27","volume-title":"Leeds Castle Symposium","author":"FS McClure","year":"1998","unstructured":"McClure FS, Jeste DV: Treatment of late-onset schizophrenia and related disorders. In Leeds Castle Symposium. Edited by Howard R. New York: Leeds Castle; 1998."},{"key":"50_CR28","volume-title":"Persistent Persecutory States of the Elderly","author":"F Post","year":"1966","unstructured":"Post F: Persistent Persecutory States of the Elderly. London: Pergamon Press; 1966."},{"key":"50_CR29","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0010-440X(84)90060-9","volume":"25","author":"P Rabins","year":"1984","unstructured":"Rabins P, Pauker S, Thomas J: Can schizophrenia begin after age 44? Compr Psychiatry 1984, 25:290\u2013293.","journal-title":"Compr Psychiatry"},{"key":"50_CR30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1532-5415.1988.tb01777.x","volume":"36","author":"TJ Craig","year":"1988","unstructured":"Craig TJ, Bregman Z: Late onset schizophrenia-like illness. J Am Geriatr Soc 1988, 36:104\u2013107.","journal-title":"J Am Geriatr Soc"},{"key":"50_CR31","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1176\/ajp.146.12.1568","volume":"146","author":"GD Pearlson","year":"1989","unstructured":"Pearlson GD, Kreger L, Rabins RV, et al.: A chart review study of late-onset and early-onset schizophrenia. Am J Psychiatry 1989, 146:1568\u20131574.","journal-title":"Am J Psychiatry"},{"key":"50_CR32","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/gps.930070908","volume":"7","author":"R Howard","year":"1992","unstructured":"Howard R, Levy R: Which factors affect treatment response in late paraphrenia? Int J Geriatr Psychiatry 1992, 7:667\u2013672.","journal-title":"Int J Geriatr Psychiatry"},{"key":"50_CR33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1532-5415.1965.tb00574.x","volume":"13","author":"G Honigfeld","year":"1965","unstructured":"Honigfeld G, Rosebaum MP, Blumenthal IJ, et al.: Behavioral improvement in the older schizophrenic patient: drug and social therapies. J Am Geriatr Soc 1965, 13:57\u201371.","journal-title":"J Am Geriatr Soc"},{"key":"50_CR34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1532-5415.1971.tb02580.x","volume":"19","author":"MM Tsuang","year":"1971","unstructured":"Tsuang MM, Lu LM, Stotsky BA, Cole JO: Haloperidol versus thioridazine for hospitalized psychogeriatric patients: double-blind study. J Am Geriatr Soc 1971, 19:593\u2013600.","journal-title":"J Am Geriatr Soc"},{"key":"50_CR35","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1001\/jama.1978.03280450032019","volume":"239","author":"MH Branchey","year":"1978","unstructured":"Branchey MH, Lee JH, Ramesh A: High-and low-potency neuroleptics in elderly psychiatric patients. JAMA 1978, 239:1860\u20131862.","journal-title":"JAMA"},{"key":"50_CR36","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","volume":"45","author":"JM Kane","year":"1988","unstructured":"Kane JM, Honigfeld G, Singer J, et al.: Clozapine for the treatment resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988, 45:789\u2013796.","journal-title":"Arch Gen Psychiatry"},{"issue":"suppl","key":"50_CR37","first-page":"31","volume":"59","author":"DE Casey","year":"1998","unstructured":"Casey DE: Effects of clozapine therapy in schizophrenic individuals at risk for tardive dyskinesia. J Clinl Psychiatry 1998, 59(suppl):31\u201337.","journal-title":"J Clinl Psychiatry"},{"key":"50_CR38","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJM199307153290303","volume":"329","author":"JMaJ Alvir","year":"1993","unstructured":"Alvir JMaJ, Lieberman JA, Safferman AZ, et al.: Clozapineinduced agranulocytosis: incidence and risk factors in the United States. N Engl J Med 1993, 329:162\u2013167.","journal-title":"N Engl J Med"},{"key":"50_CR39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4088\/JCP.v60n0109","volume":"60","author":"E Howanitz","year":"1999","unstructured":"Howanitz E, Pardo M, Smelson DA: The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia. J Clin Psychiatry 1999, 60:41\u201344.","journal-title":"J Clin Psychiatry"},{"key":"50_CR40","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1176\/ps.49.3.340","volume":"49","author":"M Sajatovic","year":"1998","unstructured":"Sajatovic M, Ramirez LF, Garver D, et al.: Clozapine therapy for older veterans. Psychiatr Serv 1998, 49:340\u2013344.","journal-title":"Psychiatr Serv"},{"key":"50_CR41","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00019442-199905000-00006","volume":"7","author":"S Madhusoodanan","year":"1999","unstructured":"Madhusoodanan S, Brecher M, Brenner R, et al.: Risperidone in the treatment of elderly patients with psychotic disorders. Am J Geriatr Psychiatry 1999, 7:132\u2013138.","journal-title":"Am J Geriatr Psychiatry"},{"key":"50_CR42","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/1099-1166(200006)15:6<506::AID-GPS146>3.0.CO;2-V","volume":"15","author":"M Davidson","year":"2000","unstructured":"Davidson M, Harvey PD, Vervarcke J, et al.: A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis-on behalf of the Risperidone Working Group. Int J Geriatr Psychiatry 2000, 15:506\u2013514.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"suppl","key":"50_CR43","first-page":"39","volume":"57","author":"DV Jeste","year":"1996","unstructured":"Jeste DV, Eastham JH, Lacro JP, et al.: Management of late-life psychosis. J Clin Psychiatry 1996, 57(suppl):39\u201345.","journal-title":"J Clin Psychiatry"},{"key":"50_CR44","unstructured":"Jeste DV, Madhusoodanan S, Barak Y, Martinez RA: Comparison of risperidone and olanzapine in elderly patients with schizophrenia and schizoaffective disorder: a randomized double-blind study [abstract]. Paper presented at the 15th Annual Meeting of American Association of Geriatric Psychiatry; Orlando, FL. February 24 to 27, 2002;"},{"key":"50_CR45","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4088\/JCP.v60n0207","volume":"60","author":"IR Katz","year":"1999","unstructured":"Katz IR, Jeste DV, Mintzer JE, et al.: Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trail. J Clin Psychiatry 1999, 60:107\u2013115.","journal-title":"J Clin Psychiatry"},{"key":"50_CR46","unstructured":"Gilmore J, McGuire G, Kennedy JS: Acute double-blind comparison of olanzapine and haloperidol in schizophrenia patients age greater than 60. Paper presented at the 15th Annual Meeting of American Association of Geriatric Psychiatry; Orlando, FL. February 24 to 27, 2002;"},{"key":"50_CR47","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/archpsyc.57.10.968","volume":"10","author":"JS Street","year":"2000","unstructured":"Street JS, Clark WS, Gannon KS, et al.: Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: A double-blind randomized, placebo-controlled trial. Arch Gen Psychiatry 2000, 10:968\u2013976.","journal-title":"Arch Gen Psychiatry"},{"key":"50_CR48","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4088\/JCP.v60n0504","volume":"60","author":"DQ McManus","year":"1999","unstructured":"McManus DQ, Arvanitis LA, Kowalcyk BB: Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. J Clin Psychiatry 1999, 60:292\u2013298.","journal-title":"J Clin Psychiatry"},{"key":"50_CR49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0149-2918(02)85003-2","volume":"24","author":"GL Stimmel","year":"2002","unstructured":"Stimmel GL, Gutierrez MA, Lee V: Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia. Clin Ther 2002, 24:21\u201337.","journal-title":"Clin Ther"},{"key":"50_CR50","first-page":"295","volume":"36","author":"AR Saha","year":"1999","unstructured":"Saha AR, Petrie JL, Ali MW: Safety and efficacy profile of aripiprazole: a novel antipsychotic. Schizophr Res 1999, 36:295\u2013296.","journal-title":"Schizophr Res"},{"key":"50_CR51","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2165\/00002512-199101040-00005","volume":"1","author":"AJ Campbell","year":"1991","unstructured":"Campbell AJ: Drug treatment as a cause of falls in old age: a review of the offending agents. Drug Aging 1991, 1:289\u2013302.","journal-title":"Drug Aging"},{"issue":"suppl","key":"50_CR52","first-page":"29","volume":"60","author":"SM Maixner","year":"1999","unstructured":"Maixner SM, Mellow AM, Tandon R: The efficacy, safety, and tolerability of antispychotics in the elderly. J Clin Psychiatry 1999, 60(suppl):29\u201341.","journal-title":"J Clin Psychiatry"},{"key":"50_CR53","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00004714-199908000-00007","volume":"19","author":"MP Caligiuri","year":"1999","unstructured":"Caligiuri MP, Lacro JP, Jeste DV: Incidence and predictors of drug-induced parkinsonism in older psychiatric patients treated with very low doses of neuroleptics. J Clin Psychopharmacol 1999, 19:322\u2013328.","journal-title":"J Clin Psychopharmacol"},{"key":"50_CR54","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Association; 2000.","edition":"edn 4"},{"key":"50_CR55","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archpsyc.1995.03950210050010","volume":"52","author":"DV Jeste","year":"1995","unstructured":"Jeste DV, Caligiuri MP, Paulsen JS, et al.: Risk of tardive dyskinesia in older patients: a prospective longitudinal study of 266 patients. Arch Gen Psychiatry 1995, 52:756\u2013765.","journal-title":"Arch Gen Psychiatry"},{"key":"50_CR56","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1176\/ajp.155.11.1521","volume":"155","author":"MG Woerner","year":"1998","unstructured":"Woerner MG, Alvir JM, Saltz BL, et al.: Prospective study of tardive dyskinesia in the elderly: rates and risk factors. Am J Psychiatry 1998, 155:1521\u20131528.","journal-title":"Am J Psychiatry"},{"key":"50_CR57","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00019442-199902000-00010","volume":"7","author":"DV Jeste","year":"1999","unstructured":"Jeste DV, Rockwell E, Harris MJ, et al.: Conventional vs. newer antipsychotics in elderly patients. Am J Geriatr Psychiatry 1999, 7:70\u201376.","journal-title":"Am J Geriatr Psychiatry"},{"key":"50_CR58","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.1991.03470170090030","volume":"266","author":"BL Saltz","year":"1991","unstructured":"Saltz BL, Woerner MG, Kane JM, et al.: Prospective study of tardive dyskinesia incidence in the elderly. JAMA 1991, 266:2402\u20132406.","journal-title":"JAMA"},{"key":"50_CR59","doi-asserted-by":"crossref","first-page":"52S","DOI":"10.1097\/00004714-198808001-00009","volume":"8","author":"JM Kane","year":"1988","unstructured":"Kane JM, Woerner M, Lieberman J: Tardive dyskinesia: prevalence, incidence, and risk factors. J Clin Psychopharmacol 1988, 8:52S-56S.","journal-title":"J Clin Psychopharmacol"},{"key":"50_CR60","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1176\/ajp.156.2.309","volume":"156","author":"DV Jeste","year":"1999","unstructured":"Jeste DV, Lacro JP, Palmer BW, et al.: Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients. Am J Psychiatry 1999, 156:309\u2013311.","journal-title":"Am J Psychiatry"},{"key":"50_CR61","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1532-5415.1999.tb01595.x","volume":"47","author":"DV Jeste","year":"1999","unstructured":"Jeste DV, Lacro JP, Bailey A, et al.: Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. J Am Geriatr Soc 1999, 47:716\u2013719.","journal-title":"J Am Geriatr Soc"},{"key":"50_CR62","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00019442-200002000-00004","volume":"8","author":"DV Jeste","year":"2000","unstructured":"Jeste DV, Glazer WM, Morgenstern H: Low incidence of persistent tardive dyskinesia with quetiapine treatment of psychotic disorders in the elderly [abstract]. Am J Geriatr Psychiatry 2000, 8:25\u201326.","journal-title":"Am J Geriatr Psychiatry"},{"key":"50_CR63","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archpsyc.59.4.337","volume":"59","author":"JW Newcomer","year":"2002","unstructured":"Newcomer JW, Haupt Dw, Fucetola R: Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch Gen Psychiatry 2002, 59:337\u2013345.","journal-title":"Arch Gen Psychiatry"},{"key":"50_CR64","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1176\/appi.ajp.159.4.561","volume":"159","author":"MJ Sernyak","year":"2002","unstructured":"Sernyak MJ, Leslie DL, Alarcon RD: Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry 2002, 159:561\u2013566.","journal-title":"Am J Psychiatry"},{"key":"50_CR65","doi-asserted-by":"crossref","unstructured":"Jin H, Meyer JM, Jeste DV: The phenomenology of new-onset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: an analysis of 45 published cases. Ann Clin Psychiatry 2002, In press.","DOI":"10.3109\/10401230209147399"},{"key":"50_CR66","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/schbul\/22.3.447","volume":"22","author":"U Halbreich","year":"1996","unstructured":"Halbreich U, Palter S: Accelerated osteoporosis in psychiatric patients: Possible pathophysiological processes. Schizophr Bull 1996, 22:447\u2013454.","journal-title":"Schizophr Bull"},{"key":"50_CR67","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(94)90542-8","volume":"344","author":"P Webster","year":"1994","unstructured":"Webster P, Wijeratne C: Risperidone-induced neuroleptic malignant syndrome. Lancet 1994, 344:1228\u20131229.","journal-title":"Lancet"},{"key":"50_CR68","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archpsyc.56.1.101","volume":"56","author":"PR Burkhard","year":"1999","unstructured":"Burkhard PR, Vingerhoets FJG, Alberque C, Landis T: Olanzapine-induced neuroleptic malignant syndrome. Arch Gen Psychiatry 1999, 56:101\u2013102.","journal-title":"Arch Gen Psychiatry"},{"key":"50_CR69","first-page":"112","volume":"52","author":"N Whaley","year":"1999","unstructured":"Whaley N, Diaz P, Howard J: Neuroleptic malignant syndrome associated with the use of quetiapine. Can J Hosp Pharmacy 1999, 52:112.","journal-title":"Can J Hosp Pharmacy"},{"key":"50_CR70","volume-title":"Principles of Geriatric Medicine and Gerontology","author":"SK Morris","year":"1997","unstructured":"Morris SK, Jeste DV: Schizophrenia and other psychotic disorders. In Principles of Geriatric Medicine and Gerontology. Edited by Hazzard WR, Blass JP, Ettinger Jr. WH, Halter JB, Ouslander JG. New York: McGraw-Hill, Inc.; 1997."},{"key":"50_CR71","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1017\/S1041610296002918","volume":"8","author":"R Howard","year":"1996","unstructured":"Howard R: Study on Schizophrenia: drug treatment of schizophrenia and delusional disorder in late life. Int Psychogeriatr 1996, 8:597\u2013608.","journal-title":"Int Psychogeriatr"},{"key":"50_CR72","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0920-9964(00)00186-9","volume":"53","author":"E Granholm","year":"2001","unstructured":"Granholm E, McQuaid JR, McClure FS, et al.: A randomized controlled pilot study of cognitive behavioral social skills training for older patients with schizophrenia. Schizophr Res 2001, 53:167\u2013169.","journal-title":"Schizophr Res"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-996-0050-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-996-0050-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-996-0050-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T04:14:03Z","timestamp":1683864843000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-996-0050-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["50"],"URL":"https:\/\/doi.org\/10.1007\/s11920-996-0050-y","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8]]}}}